Drug Shortage Report for TUBERSOL
Report ID | 54279 |
Drug Identification Number | 00317268 |
Brand name | TUBERSOL |
Common or Proper name | Tuberculin Purified Protein Derivative (Mantoux) |
Company Name | SANOFI PASTEUR LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | PURIFIED PROTEIN DERIVATIVE OF TUBERCULIN |
Strength(s) | 5TUB |
Dosage form(s) | SOLUTION |
Route of administration | INTRADERMAL |
Packaging size | 5 mL multidose vial (5 TU per test) |
ATC code | V04CF |
ATC description | OTHER DIAGNOSTIC AGENTS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2018-06-29 |
Actual start date | 2018-06-29 |
Estimated end date | Unknown |
Actual end date | 2018-07-11 |
Shortage status | Resolved |
Updated date | 2018-07-12 |
Company comments | The supply has been restored. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1755 STEELES AVENUE WEST TORONTO, ONTARIO CANADA M2R 3T4 |
Company contact information | Customer Service/Service à la clientèle: 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2018-07-04 | English | Compare |
v2 | 2018-07-04 | French | Compare |
v3 | 2018-07-11 | English | Compare |
v4 | 2018-07-11 | French | Compare |
v5 | 2018-07-12 | English | Compare |
Showing 1 to 5 of 5